{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:35:33Z","timestamp":1793144133684,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To evaluate the safety and efficacy of ophthalmic nerve stimulation (ONS), combined with ascorbic acid (AA) in the treatment of retinitis pigmentosa (RP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Forty participants with RP were enrolled in a prospective open-label single-armed intervention. Patients with non-syndromic RP; aged\u2009\u2265\u20094 years, with BCVA\u2009\u2265\u200920\/400 were included. All participants were treated with bilateral ONS sessions combined with intravenous administration of AA for two weeks. The primary efficiency endpoint was the change in scotopic vision at 6 months, assessed using 10-item, 100-point, Low Luminance Questionnaire (LLQ-10). The secondary efficiency points included BCVA and contrast sensitivity. Rod responders were defined by \u2265\u200925 points increment of LLQ-10 score at 6 months\u2019 visit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ocular neuromodulation therapy significantly improved low luminance vision, BCVA, and contrast sensitivity in patients with RP (<jats:italic>p\u2009\u2264\u20090.05<\/jats:italic>). At 6-month visits, 60% of patients were identified as rod responders. The mean change in LLQ-10 score was (46.35\u2009\u00b1\u200916.81 point) in rod responders versus (4.9\u2009\u00b1\u20097.6 point) in non-responders (<jats:italic>p\u2009&lt;\u20090.0001<\/jats:italic>). A clinically significant improvement of BCVA (\u2265\u20090.2 logMAR unit) and contrast sensitivity (\u2265\u20090.3 log unit) were demonstrated in 50% of the right eyes of rod responders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Ocular neuromodulation significantly improved night vision, BCVA, and contrast sensitivity. Determinants of rod responders include the duration of night blindness, stage of the disease, and thickness of ganglion cell layer at baseline. Two therapeutic scenarios were recognized; an early disease-modifying intervention that restores night vision and a late cone rescue intervention that improves\/maintains central vision.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00699-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:05:17Z","timestamp":1751360717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ocular neuromodulation as a novel treatment for retinitis pigmentosa: identifying rod responders and predictors of visual improvement"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-1623","authenticated-orcid":false,"given":"Ismail M","family":"Musallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"699_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1878-5085-3-17","volume":"3","author":"K Konieczka","year":"2012","unstructured":"Konieczka K, et al. Retinitis pigmentosa and ocular blood flow. EPMA J. 2012;3(1):17\u201317.","journal-title":"EPMA J"},{"issue":"Pt 2","key":"699_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/eye.1990.50","volume":"4","author":"ME Langham","year":"1990","unstructured":"Langham ME, Kramer T. Decreased choroidal blood flow associated with retinitis pigmentosa. Eye (Lond). 1990;4(Pt 2):374\u201381.","journal-title":"Eye (Lond)"},{"issue":"3","key":"699_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10633-013-9374-1","volume":"126","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Decreased retinal-choroidal blood flow in retinitis pigmentosa as measured by MRI. Doc Ophthalmol. 2013;126(3):187\u201397.","journal-title":"Doc Ophthalmol"},{"issue":"9","key":"699_CR4","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41433-022-02270-5","volume":"37","author":"S Abdolrahimzadeh","year":"2023","unstructured":"Abdolrahimzadeh S, et al. Choroidal vascularity index and choroidal thickness: potential biomarkers in retinitis pigmentosa. Eye. 2023;37(9):1766\u201373.","journal-title":"Eye"},{"issue":"4","key":"699_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9394(14)72109-9","volume":"122","author":"JE Grunwald","year":"1996","unstructured":"Grunwald JE, Maguire AM, Dupont J. Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol. 1996;122(4):502\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"699_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1139\/Y10-036","volume":"88","author":"M Cellini","year":"2010","unstructured":"Cellini M, et al. ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol. 2010;88(6):630\u20135.","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"699_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-2008-1046089","volume":"199","author":"S Wolf","year":"1991","unstructured":"Wolf S, et al. [Hemodynamic findings in patients with retinitis pigmentosa]. Klin Monbl Augenheilkd. 1991;199(5):325\u20139.","journal-title":"Klin Monbl Augenheilkd"},{"key":"699_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","volume":"64","author":"A Reiner","year":"2018","unstructured":"Reiner A, et al. Neural control of choroidal blood flow. Prog Retin Eye Res. 2018;64:96\u2013130.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"699_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/j.2040-4603.2015.tb00603.x","volume":"5","author":"DH McDougal","year":"2015","unstructured":"McDougal DH, Gamlin PD. Autonomic control of the eye. Compr Physiol. 2015;5(1):439\u201373.","journal-title":"Compr Physiol"},{"issue":"3","key":"699_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0306-4522(89)90154-1","volume":"30","author":"N Suzuki","year":"1989","unstructured":"Suzuki N, Hardebo JE, Owman C. Trigeminal fibre collaterals storing substance P and calcitonin gene-related peptide associate with ganglion cells containing choline acetyltransferase and vasoactive intestinal polypeptide in the Sphenopalatine ganglion of the rat. An axon reflex modulating parasympathetic ganglionic activity? Neuroscience. 1989;30(3):595\u2013604.","journal-title":"Neuroscience"},{"issue":"2","key":"699_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5115\/acb.2016.49.2.132","volume":"49","author":"F Hosaka","year":"2016","unstructured":"Hosaka F, et al. Human nasociliary nerve with special reference to its unique parasympathetic cutaneous innervation. Anat Cell Biol. 2016;49(2):132\u20137.","journal-title":"Anat Cell Biol"},{"issue":"2","key":"699_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0306-4522(89)90385-0","volume":"31","author":"N Suzuki","year":"1989","unstructured":"Suzuki N, Hardebo JE, Owman C. Origins and pathways of cerebrovascular nerves storing substance P and calcitonin gene-related peptide in rat. Neuroscience. 1989;31(2):427\u201338.","journal-title":"Neuroscience"},{"issue":"2","key":"699_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.1984.61.2.0307","volume":"61","author":"GA Lambert","year":"1984","unstructured":"Lambert GA, et al. Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg. 1984;61(2):307\u201315.","journal-title":"J Neurosurg"},{"issue":"1","key":"699_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"PJ Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48\u201356.","journal-title":"Ann Neurol"},{"key":"699_CR15","doi-asserted-by":"publisher","first-page":"649910","DOI":"10.3389\/fnins.2021.649910","volume":"15","author":"TG White","year":"2021","unstructured":"White TG, et al. Trigeminal nerve control of cerebral blood flow: A brief review. Front Neurosci. 2021;15:649910.","journal-title":"Front Neurosci"},{"issue":"2","key":"699_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-4835(79)90134-9","volume":"28","author":"J Stjernschantz","year":"1979","unstructured":"Stjernschantz J, Geijer C, Bill A. Electrical stimulation of the fifth cranial nerve in rabbits: effects on ocular blood flow, extravascular albumin content and intraocular pressure. Exp Eye Res. 1979;28(2):229\u201338.","journal-title":"Exp Eye Res"},{"key":"699_CR17","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1097\/00005344-198500073-00011","volume":"7","author":"A Bill","year":"1985","unstructured":"Bill A, Nilsson SF. Control of ocular blood flow. J Cardiovasc Pharmacol. 1985;7:S96\u2013102.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"699_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.biomaterials.2012.11.008","volume":"34","author":"JH Kim","year":"2013","unstructured":"Kim JH, et al. Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse Hind limb ischemia model. Biomaterials. 2013;34(6):1657\u201368.","journal-title":"Biomaterials"},{"key":"699_CR19","doi-asserted-by":"crossref","unstructured":"Lee D, Hong HS. Substance P alleviates retinal pigment epithelium dysfunction caused by high Glucose-Induced stress. Life (Basel), 2023. 13(5).","DOI":"10.3390\/life13051070"},{"issue":"2","key":"699_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yexcr.2019.04.008","volume":"380","author":"K Ou","year":"2019","unstructured":"Ou K, et al. Restoring retinal neurovascular health via substance P. Exp Cell Res. 2019;380(2):115\u201323.","journal-title":"Exp Cell Res"},{"key":"699_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2013.09.001","volume":"187","author":"J-H Yang","year":"2013","unstructured":"Yang J-H, et al. Restoration of endogenous substance P is associated with Inhibition of apoptosis of retinal cells in diabetic rats. Regul Pept. 2013;187:12\u20136.","journal-title":"Regul Pept"},{"key":"699_CR22","first-page":"1015","volume":"22","author":"SM Baek","year":"2016","unstructured":"Baek SM, et al. Substance P promotes the recovery of oxidative stress-damaged retinal pigmented epithelial cells by modulating Akt\/GSK-3\u03b2 signaling. Mol Vis. 2016;22:1015\u201323.","journal-title":"Mol Vis"},{"key":"699_CR23","first-page":"933","volume":"23","author":"K Yoo","year":"2017","unstructured":"Yoo K, et al. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-\u03b1. Mol Vis. 2017;23:933\u201343.","journal-title":"Mol Vis"},{"issue":"1","key":"699_CR24","doi-asserted-by":"publisher","first-page":"9417","DOI":"10.1038\/s41598-017-09639-7","volume":"7","author":"JE Lim","year":"2017","unstructured":"Lim JE, Chung E, Son Y. A neuropeptide, Substance-P, directly induces tissue-repairing M2 like macrophages by activating the PI3K\/Akt\/mTOR pathway even in the presence of IFN\u03b3. Sci Rep. 2017;7(1):9417.","journal-title":"Sci Rep"},{"issue":"3","key":"699_CR25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/JCI132990","volume":"130","author":"PA Campochiaro","year":"2020","unstructured":"Campochiaro PA, et al. Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial. J Clin Invest. 2020;130(3):1527\u201341.","journal-title":"J Clin Invest"},{"issue":"2","key":"699_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0300-9629(91)90470-W","volume":"100","author":"RC Rose","year":"1991","unstructured":"Rose RC, Bode AM. Ocular ascorbate transport and metabolism. Comp Biochem Physiol Comp Physiol. 1991;100(2):273\u201385.","journal-title":"Comp Biochem Physiol Comp Physiol"},{"issue":"9","key":"699_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.RES.83.9.916","volume":"83","author":"TS Jackson","year":"1998","unstructured":"Jackson TS, et al. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res. 1998;83(9):916\u201322.","journal-title":"Circ Res"},{"key":"699_CR28","unstructured":"SWOG:. Cancer Research Network\u2013 Cancer Research and Biostatistics.https:\/\/stattools.crab.org\/Calculators\/oneArmSurvivalColored.html"},{"key":"699_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","volume":"41","author":"LJ Lesko","year":"2001","unstructured":"Lesko LJ, Atkinson AJ Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41:347\u201366.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"699_CR30","doi-asserted-by":"publisher","first-page":"Bio20","DOI":"10.1167\/iovs.17-21987","volume":"58","author":"FA Medeiros","year":"2017","unstructured":"Medeiros FA. Biomarkers and surrogate endpoints: lessons learned from Glaucoma. Invest Ophthalmol Vis Sci. 2017;58(6):Bio20\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"699_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1167\/iovs.05-1222","volume":"47","author":"C Owsley","year":"2006","unstructured":"Owsley C, et al. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Invest Ophthalmol Vis Sci. 2006;47(2):528\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"699_CR32","doi-asserted-by":"publisher","first-page":"910812","DOI":"10.1155\/2014\/910812","volume":"2014","author":"H Hiraba","year":"2014","unstructured":"Hiraba H, et al. Facial vibrotactile stimulation activates the parasympathetic nervous system: study of salivary secretion, heart rate, pupillary reflex, and functional near-infrared spectroscopy activity. Biomed Res Int. 2014;2014:910812.","journal-title":"Biomed Res Int"},{"issue":"8","key":"699_CR33","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1523\/JNEUROSCI.15-08-05429.1995","volume":"15","author":"ZY Li","year":"1995","unstructured":"Li ZY, Kljavin IJ, Milam AH. Rod photoreceptor neurite sprouting in retinitis pigmentosa. J Neurosci. 1995;15(8):5429\u201338.","journal-title":"J Neurosci"},{"issue":"2","key":"699_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.celrep.2016.03.022","volume":"15","author":"W Wang","year":"2016","unstructured":"Wang W, et al. Two-Step reactivation of dormant cones in retinitis pigmentosa. Cell Rep. 2016;15(2):372\u201385.","journal-title":"Cell Rep"},{"issue":"5","key":"699_CR35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.celrep.2019.06.093","volume":"28","author":"W Wang","year":"2019","unstructured":"Wang W, et al. Metabolic deregulation of the Blood-Outer retinal barrier in retinitis pigmentosa. Cell Rep. 2019;28(5):1323\u2013e13344.","journal-title":"Cell Rep"},{"issue":"1","key":"699_CR36","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ophtha.2012.07.008","volume":"120","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):e5\u201312.","journal-title":"Ophthalmology"},{"issue":"8","key":"699_CR37","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1167\/iovs.07-1168","volume":"49","author":"D Salom","year":"2008","unstructured":"Salom D, et al. Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008;49(8):3499\u2013502.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"699_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000491775","volume":"48","author":"YX Lv","year":"2018","unstructured":"Lv YX, et al. VEGF-A and VEGF-B coordinate the arteriogenesis to repair the infarcted heart with vagus nerve stimulation. Cell Physiol Biochem. 2018;48(2):433\u201349.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"699_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0361-9230(80)80006-2","volume":"5","author":"RC Rogers","year":"1980","unstructured":"Rogers RC, et al. Afferent projections to the dorsal motor nucleus of the vagus. Brain Res Bull. 1980;5(4):365\u201373.","journal-title":"Brain Res Bull"},{"issue":"5","key":"699_CR40","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1096\/fj.201903236R","volume":"34","author":"L Liu","year":"2020","unstructured":"Liu L, Dana R, Yin J. Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling. Faseb J. 2020;34(5):6229\u201343.","journal-title":"Faseb J"},{"issue":"1","key":"699_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.110.169128","volume":"58","author":"MJPMT Meens","year":"2011","unstructured":"Meens MJPMT, et al. Calcitonin Gene-Related peptide terminates Long-Lasting vasopressor responses to endothelin 1 in vivo. Hypertension. 2011;58(1):99\u2013106.","journal-title":"Hypertension"},{"issue":"2","key":"699_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0026-2862(90)90024-L","volume":"40","author":"M Ziche","year":"1990","unstructured":"Ziche M, et al. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990;40(2):264\u201378.","journal-title":"Microvasc Res"},{"key":"699_CR43","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2147\/OPTH.S14573","volume":"4","author":"T Kurimoto","year":"2010","unstructured":"Kurimoto T, et al. Transcorneal electrical stimulation increases chorioretinal blood flow in normal human subjects. Clin Ophthalmol. 2010;4:1441\u20136.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"699_CR44","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/aos.13581","volume":"96","author":"AK Bittner","year":"2018","unstructured":"Bittner AK, et al. Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa. Acta Ophthalmol. 2018;96(3):e366\u201376.","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"699_CR45","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1097\/CCM.0000000000003735","volume":"47","author":"C Li","year":"2019","unstructured":"Li C, et al. Trigeminal nerve stimulation: A novel method of resuscitation for hemorrhagic shock. Crit Care Med. 2019;47(6):e478\u201384.","journal-title":"Crit Care Med"},{"issue":"13","key":"699_CR46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/WNR.0b013e3283572206","volume":"23","author":"MH Jiang","year":"2012","unstructured":"Jiang MH, et al. Substance P induces M2-type macrophages after spinal cord injury. NeuroReport. 2012;23(13):786\u201392.","journal-title":"NeuroReport"},{"issue":"6","key":"699_CR47","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1167\/iovs.03-0845","volume":"45","author":"DY Yu","year":"2004","unstructured":"Yu DY, et al. Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci. 2004;45(6):2013\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"699_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.regpep.2005.03.007","volume":"130","author":"C Schmid","year":"2005","unstructured":"Schmid C, Ghirlanda-Keller C, Gosteli-Peter M. Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells. Regul Pept. 2005;130(1\u20132):57\u201366.","journal-title":"Regul Pept"},{"issue":"3","key":"699_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0196-9781(94)90212-7","volume":"15","author":"L Wang","year":"1994","unstructured":"Wang L, et al. Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides. 1994;15(3):497\u2013503.","journal-title":"Peptides"},{"issue":"22","key":"699_CR50","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","volume":"73","author":"A Mashaghi","year":"2016","unstructured":"Mashaghi A, et al. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016;73(22):4249\u201364.","journal-title":"Cell Mol Life Sci"},{"issue":"30","key":"699_CR51","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1073\/pnas.0604056103","volume":"103","author":"K Komeima","year":"2006","unstructured":"Komeima K, et al. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2006;103(30):11300\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"699_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000505001","volume":"63","author":"JK Jolly","year":"2020","unstructured":"Jolly JK, et al. Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: A multicenter safety study of the OkuStim\u00ae system (TESOLA-Study). Ophthalmic Res. 2020;63(3):234\u201343.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"699_CR53","doi-asserted-by":"publisher","first-page":"11668","DOI":"10.1038\/s41598-019-48158-5","volume":"9","author":"G Miura","year":"2019","unstructured":"Miura G, et al. Clinical trial to evaluate safety and efficacy of transdermal electrical stimulation on visual functions of patients with retinitis pigmentosa. Sci Rep. 2019;9(1):11668.","journal-title":"Sci Rep"},{"issue":"5","key":"699_CR54","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.brs.2020.05.014","volume":"13","author":"F de Rossi","year":"2020","unstructured":"de Rossi F, et al. Transorbital electrical stimulation in retinitis pigmentosa. Better results joining visual pattern stimulation? Brain Stimul. 2020;13(5):1173\u20134.","journal-title":"Brain Stimul"},{"issue":"1","key":"699_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MLG.0b013e318156599d","volume":"118","author":"M Scheibe","year":"2008","unstructured":"Scheibe M, van Thriel C, Hummel T. Responses to trigeminal irritants at different locations of the human nasal mucosa. Laryngoscope. 2008;118(1):152\u20135.","journal-title":"Laryngoscope"},{"issue":"1","key":"699_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/cne.23672","volume":"523","author":"JY Bae","year":"2015","unstructured":"Bae JY, et al. Quantitative analysis of afferents expressing substance P, calcitonin gene-related peptide, isolectin B4, neurofilament 200, and peripherin in the sensory root of the rat trigeminal ganglion. J Comp Neurol. 2015;523(1):126\u201338.","journal-title":"J Comp Neurol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00699-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:04:56Z","timestamp":1751364296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00699-w","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to publish the photographs of the patient was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Ismail Musallam has US and Israeli patents licensed to himself for which he has waived financial interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board, and it adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants or legal guardians after an explanation of the purpose and possible outcome of therapy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}}],"article-number":"73"}}